US coverage decision "will provide sustained ICDs (implantable cardioverter defibrillators) growth"
This article was originally published in Clinica
Executive Summary
The US Centers for Medicare & Medicaid Services (CMS) has finally agreed to expand its coverage of implantable cardioverter defibrillators (ICDs) to nearly 500,000 potential beneficiaries deemed at possible risk of experiencing sudden cardiac arrest. "By increasing the use of defibrillators, we are striking a blow against the leading cause of death among older Americans," said CMS administrator Mark McClellan.